Luxembourg-based venture capital specialist Vesalius Biocapital has closed the first round of Biocapital III...
Up To Date
Latest News
German Merck KGaA has developed a new genome editing tool dubbed “proxy-CRISPR” providing access to previously...
Astellas Pharma Inc. has completed the acquisition of Ogeda SA (previously Euroscreen SA, Gosselies, Belgium)....
Swiss Vifor Pharma has agreed to acquire shares of Cambridge-based distributor Adebia worth US$50m in order...
AstraZeneca’s anti PD-L1 antibody durvalumab has met the co-primary endpoint in non-small cell lung cancer...
Dutch Norgine BV will take-over Merus Labs International Inc. Under the agreement, Norgine will acquire all...